arrow
T

Tina Bagratuni

National and Kapodistrian University of Athens
H指数:21
被引数:2,003

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Prospective Study of Familial Predisposition in Plasma Cell Dyscrasias

家族性易感性在浆细胞异常中的前瞻性研究

2026-07-220
OA
Prognostic value of MYD88/CXCR4 mutation allele fraction in Waldenström macroglobulinemia using a multiplex ddPCR assay

MYD88/CXCR4突变等位基因分数在瓦尔登斯特罗姆巨球蛋白血症中的预后价值:使用多重ddPCR测定法

2026-06-150
OAAI
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma

欧洲骨髓瘤网络工作组关于下一代测序在 newly diagnosed multiple myeloma 预后分层中应用的共识声明

2025-10-130
OAAI
Genomic landscape of IgM-MGUS and stable versus progressive asymptomatic Waldenström macroglobulinemia patients

IgM-MGUS及稳定期与进展期无症状华氏巨球蛋白血症患者的基因组景观

Blood
IF23.1
2025-09-290
PRE
Determining the Mutational Landscape of Waldenstrom's Macroglobulinemia By Liquid Biopsy: Results of the Prospective Ecwm-2 Trial of the European Consortium for Waldenstrom's Macroglobulinemia

通过液体活检确定华氏巨球蛋白血症的突变景观:欧洲华氏巨球蛋白血症联盟前瞻性Ecwm-2试验的结果

BLOOD
IF23.1
2024-11-050
PRE
Report of Consensus Panel 3 from the 11th International workshop on Waldenstrom's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenstrom's Macroglobulinemia

第11届瓦尔登斯特伦巨球蛋白血症国际研讨会共识小组3的报告: 瓦尔登斯特伦巨球蛋白血症的分子诊断建议

2023-03-019
OAAI
Diagnostics in Waldenstrom's macroglobulinemia: a consensus statement of the European Consortium for Waldenstrom's Macroglobulinemia
LEUKEMIA
IF13.4
2022-11-2622
OAAI
Newly Diagnosed Multiple Myeloma Patients with Skeletal-Related Events and Abnormal MRI Pattern Have Poor Survival Outcomes: A Prospective Study on 370 Patients

伴有骨骼相关事件和MRI异常的新诊断多发性骨髓瘤患者的生存结局较差: 一项针对370例患者的前瞻性研究

2022-05-302
OAAI
Patients With Autoimmune Thyroiditis Present Similar Immunological Response to COVID-19 BNT162b2 mRNA Vaccine With Healthy Subjects, While Vaccination May Affect Thyroid Function: A Clinical Study
2022-02-2216
OAAI
Kinetics of anti-SARS-CoV-2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy

淀粉样变患者接种BNT162b2疫苗后anti-SARS-CoV-2中和抗体发展的动力学及治疗的影响

2021-11-234
OA
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naive recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients

BNT162b2 mRNA疫苗的恢复期和幼稚接受者与新型冠状病毒肺炎患者的SARS-CoV-2抗刺突蛋白RBD igg和中和抗体的比较动力学

2021-08-2350
OAAI